13 assistance programs for Darzalex Faspro patients · 9 open today
Two Janssen programs: the CarePath / J&J withMe Savings Program, a commercial copay card that brings each dose to as little as $5, and the Johnson & Johnson Patient Assistance Foundation, free drug for uninsured patients — neither reaches a Medicare patient's coinsurance.
Select the patient's insurance to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links · verified July 31, 2026
Darzalex Faspro · Multiple myeloma · Commercial insurance
Eligible patients may pay $5 per dose
Example · Darzalex Faspro · 1800 mg · 180 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With Janssen CarePath Savings Program | |
|---|---|---|
| Drug responsibility | $2,053.84 | $5.00 |
| Administration (96401) | $14.36 | $14.36 |
| Patient owes | $2,068.20 | $19.36 |
Estimated patient savings: $2,048.84
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Maximum award Contact Good Days
Good Days fund for government-insured patients with Multiple Myeloma (confirmed diagnosis).
Maximum award $10,000
PAN Foundation fund for government-insured patients with Multiple myeloma (confirmed diagnosis).
Also available if this patient’s coverage falls short
Free Johnson & Johnson Patient Assistance Foundation for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
| Task | ✓ |
|---|---|
| Find programs for this insurance type | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — Eligible commercially insured patients may qualify for the Janssen CarePath / J&J withMe Savings Program. Patients pay as little as $5 per dose; a maximum program benefit applies per calendar year, but Janssen does not publish the amount. The card covers the drug only — the $71.81 96401 injection and the pre-medications (acetaminophen, an antihistamine and a corticosteroid) are the patient's. View current program ↑
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Darzalex Faspro; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. The Johnson & Johnson Patient Assistance Foundation is not a fallback either: it is open only to uninsured patients. On a 1,800 mg visit, a Medicare patient's 20% coinsurance is $2,068.20 on $10,340.99 allowed against $19.36 with the card ($5 for the drug plus the $14.36 share of the 96401 injection) — and that gap recurs on every one of the 23 doses in the first year. View current options ↑
Medicaid — The Janssen CarePath / J&J withMe Savings Program's own eligibility terms exclude Medicaid alongside Medicare, TRICARE, VA and other government programs, for the same Anti-Kickback reasons.
Uninsured — Call 800-652-6227 to start a Johnson & Johnson Patient Assistance Foundation application for free Darzalex Faspro, shipped to the provider for up to a year and renewable annually, since the foundation's own site, jjpaf.org, has been unreachable on https, the https apex and http since at least August 2026. Janssen's own patient-support entry at jnjwithme.com/patient/darzalex/withme/cost-support is a working starting point for an uninsured patient in the meantime; the foundation itself covers the drug only, not the 96401 injection fee or the office visit.
Why status matters — A program can move between three states: Open (taking new applications), Waitlist (paused, not enrolling right now), and Closed (not accepting applications). Each card on this page names the state Janssen or the foundation published and the date CareCost last checked it.
Why the product name matters — Darzalex Faspro and Darzalex (IV) are two formulations of the same antibody from the same manufacturer. Confirm which one the patient is prescribed before applying, and see the note above for what changes on the claim.
Yes. The Janssen CarePath / J&J withMe Savings Program is Janssen's commercial-only copay card for Darzalex Faspro: eligible patients pay as little as $5 per dose. A maximum program benefit applies per calendar year, but Janssen does not publish the amount. It covers the drug only, not the $71.81 96401 injection or the pre-medications. Apply on J&J withMe ↗ Calculate cost with the program →
No. Patients using Medicare, Medicaid, TRICARE, VA or other government insurance to pay for Darzalex Faspro are not eligible for the Janssen CarePath / J&J withMe Savings Program, per federal Anti-Kickback Statute rules on copay coupons. The Johnson & Johnson Patient Assistance Foundation is not a fallback either — it covers uninsured patients only. On a 1,800 mg visit, a Medicare patient's 20% coinsurance is $2,068.20 on $10,340.99 allowed, against $19.36 with the card ($5 for the drug plus the $14.36 share of the 96401 injection). Check current options ↑
Yes. The Johnson & Johnson Patient Assistance Foundation ships free Darzalex Faspro to the provider for qualifying uninsured patients, for up to a year, renewable annually. It does not cover the 96401 injection fee or the office visit. Check today's status ↑
Only against the drug copay, and even then a maximum program benefit applies per calendar year — Janssen does not publish the amount. One 1,800 mg dose of Darzalex Faspro is $10,269.18 at the Medicare-allowed drug rate, plus $71.81 for the 96401 injection. A commercially insured patient on the card pays $5 of the drug cost plus their normal share of the injection; a Medicare patient, who cannot use the card, owes $2,068.20 for the same visit.
Data current: programs verified Jul 31, 2026
Janssen CarePath / J&J withMe Savings Program · Johnson & Johnson Patient Assistance Foundation. Every program links directly to its official source or application page.
Last program check: .
Reviewed September 19, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost